Rose Diagnostics
Carlsbad, US · Founded 2023 · Delaware corporation
Founders & leadership
AV
Adolfo VelazquezNamed on SEC filing
DP
Donna PadavanNamed on SEC filing
AM
Andrew MorrisNamed on SEC filing
EB
Eric BrouwerNamed on SEC filing
Board
PG
Paul GoldBoard director
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 2 rounds · 2024–2025
▶$2.3MraisedMay 2025 · 18 investors · Other Health CareRule 506(b)
▶$2.3MraisedMay 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adolfo VelazquezExecutive Officer, Director
- Donna PadavanExecutive Officer, Director
- Andrew MorrisExecutive Officer, Director
- Eric BrouwerExecutive Officer, Director
- Paul GoldDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- Minimum investment
- $5K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedJun 2024 · 13 investors · Other TechnologyRule 506(b)
▶$1MraisedJun 2024 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Adolfo VelazquezExecutive Officer, Director
- Paul GoldDirector
- Eric BrouwerExecutive Officer, Director
- Donna PadavanExecutive Officer, Director
- Andrew MorrisExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Rose Diagnostics raised?
- Rose Diagnostics has disclosed $3.3M raised across 2 rounds.
- Where is Rose Diagnostics headquartered?
- Rose Diagnostics is headquartered in Carlsbad, US.